DNMT1 alterations have been described in colorectal cancer [42], whereas DNMT3A mutations have been often reported in myelodysplastic syndromes (MDS) and are associated with poor survival in acute myeloid leukemia (AML) [43,44]. This evidence concerns the gene DNMT1 and acute myeloid leukemia.